Communicators

are winners!

News

06.09.2019
Medigene AG: Medigene participates at upcoming conferences

Business news for the stock market

 

Martinsried/ Munich (06.09.2019) - Medigene AG (FSE: MDG1, Prime Standard) today announced its participation at the following upcoming scientific and investor conferences. Medigene's management and/or scientists will be available for one-on-one meetings at these events.

 

CAR TCR Summit

Date: 10 - 13 September 2019

Location: Boston, USA

 

DG-GT Theme Day "CAR-T cells and beyond"

Date: 16 - 17 September 2019

Location: Leipzig, Germany

 

Berenberg Bank and Goldman Sachs German Corporate Conference

Date: 23 - 25 September 2019

Location: Munich, Germany

 

ESMO - European Society for Medical Oncology Congress

Date: 27 September - 01 October 2019

Location: Barcelona, Spain

 

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.

 

For more information, please visit http://www.medigene.com

 

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

 

Contact Medigene AG

Dr Gary Waanders,

Claudia Burmester, Dr Anna Niedl

Tel.: +49 - 89 - 20 00 33 - 33 01,

email: investor@medigene.com

 

(end)

 

Emitter: Medigene AG

Address: Lochhamer Straße 11, 82152 Planegg

Country: Germany

Contact person: Medigene PR/IR

Phone: +49 - 89 - 20 00 33 - 33 01

E-mail: investor@medigene.com

Website: www.medigene.de

 

ISIN(s): DE000A1X3W00 (share)

stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate

 



NEWSLETTER REGISTRIERUNG:



Aktuelle Pressemeldungen dieses Unternehmens direkt in Ihr Postfach:
Newsletter...

Mitteilung übermittelt durch IRW-Press.com. Für den Inhalt ist der Aussender verantwortlich.

Kostenloser Abdruck mit Quellenangabe erlaubt.
